Valiant Laboratories announces the transfer of a 34.26% stake (1.86 crore shares) from Dhanvallabh Ventures to Valiant Organics, following restructuring plans. The transaction aligns with SEBI Takeover Regulations and will take place at or below ₹62.7 per share.

Valiant Labs will disclose their Q4 and full-year 2026 financial results during a board meeting on May 14th. Trading of the company's stocks is currently suspended due to insider trading regulations until May 16th.